SNDL Inc. Files Form 6-K with May 2 News Release
Ticker: SNDL · Form: 6-K · Filed: 2024-05-02T00:00:00.000Z
Sentiment: neutral
Topics: filing, news-release, reporting
TL;DR
SNDL filed a 6-K on May 2nd, including a news release. CFO Alberto Paredero-Quiros signed off.
AI Summary
SNDL Inc. filed a Form 6-K on May 2, 2024, to report a news release dated May 2, 2024. The filing indicates that SNDL Inc. is a foreign private issuer and will file annual reports under Form 40-F. The company's Chief Financial Officer, Alberto Paredero-Quiros, signed the report.
Why It Matters
This filing serves as an update for investors regarding the company's reporting status and includes a news release, which may contain material information about SNDL Inc.'s business operations or financial performance.
Risk Assessment
Risk Level: low — This filing is primarily procedural, indicating the submission of a news release and confirming the company's reporting form, with no immediate financial or operational disclosures that would suggest high risk.
Key Players & Entities
- SNDL Inc. (company) — Registrant
- Alberto Paredero-Quiros (person) — Chief Financial Officer
- May 2, 2024 (date) — Filing and News Release Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is to report a news release dated May 2, 2024, and to indicate that SNDL Inc. will file its annual reports under cover of Form 40-F.
Who signed the Form 6-K on behalf of SNDL Inc.?
The Form 6-K was signed by Alberto Paredero-Quiros, Chief Financial Officer of SNDL Inc.
What is SNDL Inc.'s principal executive office address?
SNDL Inc.'s principal executive offices are located at #300, 919 - 11 Avenue SW, Calgary, AB T2R 1P3.
What is the Commission File Number for SNDL Inc.?
The Commission File Number for SNDL Inc. is 001-39005.
What is the SIC code for SNDL Inc.?
The Standard Industrial Classification (SIC) code for SNDL Inc. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
From the Filing
0001279569-24-000515.txt : 20240502 0001279569-24-000515.hdr.sgml : 20240502 20240502122846 ACCESSION NUMBER: 0001279569-24-000515 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20240502 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SNDL Inc. CENTRAL INDEX KEY: 0001766600 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39005 FILM NUMBER: 24906639 BUSINESS ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 BUSINESS PHONE: 14039485227 MAIL ADDRESS: STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY STATE: A0 ZIP: T2R1P3 FORMER COMPANY: FORMER CONFORMED NAME: Sundial Growers Inc. DATE OF NAME CHANGE: 20190131 6-K 1 sndl6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-39005 SNDL INC. (Registrant’s name) #300, 919 - 11 Avenue SW Calgary, AB T2R 1P3 Tel.: (403) 948-5227 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☐ Form 40-F ☒ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SNDL INC. Date: May 2, 2024 By: /s/ Alberto Paredero-Quiros Name: Alberto Paredero-Quiros Title: Chief Financial Officer EXHIBIT Exhibit Description of Exhibit 99.1 News Release dated May 2, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED MAY 2, 2024 Exhibit 99.1 SunStream USA Poised to Acquire Cannabis Assets CALGARY, AB, May 2, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) (" SNDL "), through its joint venture in SunStream Bancorp Inc. (" SunStream Bancorp "), today announced the SunStream USA group of companies (collectively, " SunStream USA Group ") intends to proceed with the acquisition of equity positions in U.S. cannabis assets. This follows the completion of a review by SNDL's listing authority, Nasdaq. SNDL has been in regular and active dialogue with Nasdaq, in respect of structuring and governance related to the SunStream USA Group. Based on SNDL's opinion of counsel and Nasdaq's review, SNDL is satisfied that the SunStream USA Group structure conforms to applicable laws and is not aware of any reason that would cause SNDL to not be compliant with Nasdaq listing rules (" Regulatory Compliance "). All financial information in this press release is reported in U.S. dollars unless otherwise indicated. SunStream USA I, LLC (" SSU I ") and SunStream USA II, LLC (" SSU II ", and with SSU I, " SunStream USA ") are among the entities today that comprise the SunStream USA Group. Each entity includes one or more third-party investors, which are independently managed and governed. SNDL's affiliate, SunStream Opportunities II LP, is anticipated to own non-voting and non-participating exchangeable securities in the SunStream USA entities (" SSU Exchangeable Securities "). SNDL will not consolidate the financial statements of any entity within the SunStream USA Group until such time it is permissible to do so under applicable law and listing regulations. SNDL, as a capital sponsor of the SunStream USA Group and through SunStream Opportunities II LP, would be afforded prospective economic interests in SunStream USA, through the SSU Exchangeable Securities. With SNDL having satisfied itself on Regulatory Compliance matters, SunStream USA is now braced to acquire ce